Table 3.
Relative abundance at the phylum level in patients with dCCA and the onset of common bile duct stones.
| Phylum | mean (group_T) | sd (group_T) | mean (group_C) | sd (group_C) | p value |
|---|---|---|---|---|---|
| Chloroflexi | 0.001255 | 0.001756 | 0.000036 | 0.000142 | 0.000650 |
| Gemmatimonadetes | 0.000295 | 0.000547 | 0 | 0 | 0.000930 |
| Nitrospirae | 0.000704 | 0.001973 | 0 | 0 | 0.000930 |
| Unclassified_Bacteria | 0.118056 | 0.095475 | 0.029619 | 0.074029 | 0.002429 |
| Latescibacteria | 0.000600 | 0.001697 | 0 | 0 | 0.021911 |
| Planctomycetes | 0.000545 | 0.001069 | 0.000002 | 0.000009 | 0.039550 |
The dCCA group (Tumor group, T), the new onset of CBD stones group (CBD stones group, C), and recurrent CBD stones group (Post-ERCP CBD stones group, P) denoted as “Group T”, “Group C”, and “Group P”, respectively, in the table.